Networking at a senescent level

Cells

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

The Senolytic Therapy Network is advancing the fight against aging with outreach and research initiatives – we speak to a co-founder.

The Senolytic Therapy Network (STN) was founded to serve as the premier organisation for studying and implementing senolytic therapies into clinical practice. With a firm belief that successful senolytic therapies are the necessary next step in advancing the fight against aging and promoting successful organ and tissue regeneration, the Network works with practitioners across the globe to educate healthcare professionals about the science behind senolytics and senotherapeutics, advancing the field and supporting research initiatives that can further diagnostic and therapeutic aspects as they relate to cellular senescence and senolytics.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE